Ewing sarcoma of bone (Cancer)

Search with Google Search with Bing
Information
Disease name
Ewing sarcoma of bone
Disease ID
DOID:3368
Description
"A peripheral primitive neuroectodermal tumor that is located_in bone." [url:http\://en.wikipedia.org/wiki/Ewing%27s_sarcoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00618813 Completed N/A Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors March 2008
NCT05024253 Completed Phase 3 Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. August 2, 2021 February 1, 2024
NCT00674193 Completed Evaluating Dactinomycin and Vincristine in Young Patients With Cancer February 2008
NCT00516295 Completed Phase 2 Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma February 2008 January 2010
NCT01825902 Completed Early Phase 1 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma March 2013 November 23, 2015
NCT03968471 Completed Chemotherapy-induced Necrosis in Ewing Sarcoma May 13, 2019 January 15, 2020
NCT06068075 Recruiting N/A Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD May 8, 2018 January 1, 2026
NCT04845893 Recruiting Observational Study on Skeletal Ewing's Sarcoma June 1, 2021 May 25, 2028
NCT05033288 Recruiting Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone January 20, 2022 August 30, 2028
NCT05395741 Recruiting Phase 1/Phase 2 Regorafenib in Patients With Refractory Primary Bone Tumors April 28, 2022 December 31, 2025
NCT01795430 Withdrawn N/A Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma July 2013
NCT05116800 Withdrawn Phase 2 Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma March 1, 2022 August 2030
Disase is a (Disease Ontology)
DOID:3369
Cross Reference ID (Disease Ontology)
NCI:C35871
Cross Reference ID (Disease Ontology)
NCI:C4835
Cross Reference ID (Disease Ontology)
NCI:C6623
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:307608006
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0585474
Cross Reference ID (Disease Ontology)
UMLS_CUI:C1333481
Cross Reference ID (Disease Ontology)
UMLS_CUI:C1334406
Exact Synonym (Disease Ontology)
bone Ewing sarcoma
Exact Synonym (Disease Ontology)
bone localized Ewing sarcoma
Exact Synonym (Disease Ontology)
bone localized Ewing's sarcoma
Exact Synonym (Disease Ontology)
Ewing's sarcoma/bone peripheral primitive neuroectodermal tumor
Exact Synonym (Disease Ontology)
localized Skeletal Ewing's sarcoma
Disase Synonym (Disease Ontology)
bone Ewing's sarcoma
Disase Synonym (Disease Ontology)
Ewing's sarcoma of bone